pt. 1, 28, no. 12 (December 1982): 29198, e pt. 2, 29, no. 1 (January 1983): 812, e pt. 3, 31, no. 9 (September 1985): 17680; e Sidell, 469.38. Sidell, 46778; Cieslak e Eitzen, 55255; Dragon, 295301; Philip S. Brachman e Arthur M. Friedlander, Anthrax, in Stanley A. Plotkin e Walter A. Orenstein, Vaccines,3d ed. (Philadelphia: W. B. Saunders, 1999), 62938; e A. Watson e D. Keir, Information on which to base assessments of risk from environments contaminated with anthrax spores, Epidemiol Infect 113 (1994): 47990.39. Brachman e Friedlander, 62938.40. Terry C. Dixon et al., Anthrax, New England Journal of Medicine 341, no. 11 (September 1999): 818.41. Ibid., 815.42. Ibid.; Wilkening, 76114; Pentagon Spokesmans Regular Briefing; DoD Response to the Staff Report of the House Government Reforms Subcommittee on National Security, 39; J. F. Mazzuchi et al., Protecting the Health of U.S. Military Forces: A National Obligation, Aviation, Space, and Environmental Medicine 71, no. 3 (March 2000): 26065; e Ronal M. Atlas, The Medical Threat of Biological Weapons, Critical Issues in Microbiology 24, no. 3 (1998): 15767.43. Cieslak e Eitzen, 55255.44. Ibid.45. Ibid.; e Brachman e Friedlander, 62938.46. Dragon, 295.47. Watson, 47990; e Thomas V. Inglesby et al., Anthrax as a Biological Weapon: Medical and Public Health Management, Journal of the American Medical Association281 (May 1999): 173545.48. Watson, 47990; Inglesby, 173545; e Brachman e Friedlander, 62938.49. Cieslak e Eitzen, 553; e Dixon et al., 818.50. Information about the Anthrax Vaccine, 18.51. Kenneth Berns et al., Preventing the Misuse of Microorganisms: The Role of the American Society for Microbiology in Protecting against Biological Weapons, Critical Issues in Microbiology 24, no. 3 (1998): 274.52. Hoffman, A17; e Lt Col George W. Christopher et al., Biological Warfare: A Historical Perspective, Journal of the American Medical Association 278, no. 5 (August 1997): 416.53. Alibek e Handelman, 75; Christopher, 416; Hoffman, A17; e Jeanne Guillemin, Anthrax: The Investigation of a Deadly Outbreak (Berkeley, Calif.: University of California Press, 1999).54. Christopher, 414.55. Pentagon Spokesmans Regular Briefing.56. Exposicao, Jerry Brubaker, Defense Threat Reduction Agency, Air War College, Maxwell AFB, Ala., 1994.57. Carus, Bioterrorism and Biocrimes, 5758.58. Atlas, 15767.59. Jane M. Orient, Chemical and Biological Warfare: Should Defenses Be Researched and Deployed? Journal of the American Medical Association 262 (August 1989): 64448.60. Atlas, 15767; e John C. Gannon, The US Intelligence Community and the Challenge of BCW, in The New Terror: Facing the Threat of Biological and Chemical Weapons,129.61. Berns, 275.62. Information about the Anthrax Vaccine, 3.63. DoD Response to the Staff Report of the House Government Reforms Subcommittee on National Security, 3; e Pentagon Spokesmans Regular Briefing.64. Atlas, 161.65. Pentagon Spokesmans Regular Briefing; e DoD Response to the Staff Report of the House Government Reforms Subcommittee on National Security, 2.66. Atlas, 15756.67. Pentagon Spokesmans Regular Briefing.68. Ibid.; e Information about the Anthrax Vaccine, 3.69. Dragon, 296.70. Ibid.; Watson 47990; e Dixon, 815.71. Brad Roberts, Export Controls and Biological Weapons: New Roles, New Challenges, Critical Issues in Microbiology 24, no. 3 (1998): 239.72. Information about the Anthrax Vaccine, 3; e DoD Response to the Staff Report of the House Government